ClinicalTrials.govpublic full text
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
breast cancer, stage ia breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage ib breast cancer, estrogen receptor-negative breast cancer, progesterone receptor-negative breast cancer, triple-negative breast cancer, low-dose maintenance chemotherapy, stroma, angiogenesis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 887657
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.